FI961418L - Azolderivat och dess farmaceutisk blandning - Google Patents
Azolderivat och dess farmaceutisk blandning Download PDFInfo
- Publication number
- FI961418L FI961418L FI961418A FI961418A FI961418L FI 961418 L FI961418 L FI 961418L FI 961418 A FI961418 A FI 961418A FI 961418 A FI961418 A FI 961418A FI 961418 L FI961418 L FI 961418L
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical composition
- azole derivative
- azole
- derivative
- pharmaceutical
- Prior art date
Links
- 150000007980 azole derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24494493 | 1993-09-30 | ||
PCT/JP1994/001593 WO1995009157A1 (en) | 1993-09-30 | 1994-09-28 | Azole derivative and pharmaceutical composition thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
FI961418A0 FI961418A0 (sv) | 1996-03-29 |
FI961418L true FI961418L (sv) | 1996-03-29 |
Family
ID=17126291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961418A FI961418L (sv) | 1993-09-30 | 1996-03-29 | Azolderivat och dess farmaceutisk blandning |
Country Status (12)
Country | Link |
---|---|
US (1) | US5807880A (sv) |
EP (1) | EP0721943A4 (sv) |
KR (1) | KR960704852A (sv) |
CN (1) | CN1131944A (sv) |
AU (1) | AU679119B2 (sv) |
CA (1) | CA2170874A1 (sv) |
FI (1) | FI961418L (sv) |
HU (1) | HUT75871A (sv) |
NO (1) | NO961274L (sv) |
NZ (1) | NZ273681A (sv) |
PL (1) | PL313769A1 (sv) |
WO (1) | WO1995009157A1 (sv) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998006720A1 (fr) | 1996-08-09 | 1998-02-19 | Eisai Co., Ltd. | Derives de benzopiperidine |
AU6229698A (en) * | 1997-02-21 | 1998-09-09 | Takeda Chemical Industries Ltd. | Fused ring compounds, process for producing the same and use thereof |
HUP0004037A3 (en) * | 1997-10-02 | 2002-03-28 | Daiichi Seiyaku Co | Novel dihydronaphthalene compounds and process for producing the same |
US6559157B2 (en) | 1997-10-02 | 2003-05-06 | Daiichi Pharmaceutical Co., Ltd. | Dihydronaphthalene compounds |
CA2328973A1 (en) * | 1998-04-23 | 1999-10-28 | Akio Ojida | Naphthalene derivatives, their production and use |
JP4546589B2 (ja) * | 1998-04-23 | 2010-09-15 | 武田薬品工業株式会社 | ナフタレン誘導体 |
JP4520012B2 (ja) * | 1999-10-22 | 2010-08-04 | 武田薬品工業株式会社 | 1−置換−1−(1h−イミダゾール−4−イル)メタノール類 |
PE20010781A1 (es) | 1999-10-22 | 2001-08-08 | Takeda Chemical Industries Ltd | Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion |
DE60027034T2 (de) | 1999-10-22 | 2006-11-09 | Takeda Pharmaceutical Co. Ltd. | 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung |
EP1334106B1 (en) | 2000-11-17 | 2006-05-24 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, production method thereof and use thereof |
CA2429437A1 (en) | 2000-11-20 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Imidazole derivatives, process for their preparation and their use |
WO2002046186A1 (fr) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation |
CA2519211A1 (en) * | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | Release control compositions |
WO2008021250A2 (en) * | 2006-08-10 | 2008-02-21 | Fred Hutchinson Cancer Research Center | Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins |
AU2010264698C1 (en) | 2009-06-26 | 2013-05-16 | Novartis Ag | 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17 |
WO2011041737A2 (en) | 2009-10-02 | 2011-04-07 | Fred Hutchinson Cancer Research Center | Gain-of-function bcl-2 inhibitors |
WO2011041731A2 (en) | 2009-10-02 | 2011-04-07 | Fred Hutchinson Cancer Research Center | Method of inhibiting bcl-2-related survival proteins |
KR101594660B1 (ko) | 2010-08-04 | 2016-02-16 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
EP2627648A1 (en) | 2010-09-16 | 2013-08-21 | Novartis AG | 17aHYDROXYLASE/C17,20-LYASE INHIBITORS |
CA2820718A1 (en) * | 2010-12-13 | 2012-06-21 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
KR20140025492A (ko) | 2011-04-28 | 2014-03-04 | 노파르티스 아게 | 17α-히드록실라제/C17,20-리아제 억제제 |
JP5990059B2 (ja) * | 2012-08-03 | 2016-09-07 | 花王株式会社 | StAR発現抑制剤 |
JP6275378B2 (ja) * | 2012-12-26 | 2018-02-07 | エヌ・イーケムキャット株式会社 | カルバゾール類の製造方法およびこの方法により製造されたカルバゾール類。 |
CA2902335C (en) | 2013-03-14 | 2021-09-14 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
AU2015314772B2 (en) | 2014-09-12 | 2020-02-27 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
WO2018080933A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
CN109748884B (zh) * | 2019-02-19 | 2022-06-24 | 成都恒昊创新科技有限公司 | 一种铁死亡抑制剂及其制备方法与应用 |
EP3786156B1 (en) * | 2018-04-27 | 2024-06-05 | Chengdu Henghao Investment Co. Limited | 10h-phenothiazine ferroptosis inhibitor and preparation method therefor and application thereof |
WO2021098715A1 (zh) * | 2019-11-21 | 2021-05-27 | 成都恒昊投资有限公司 | 一种吩噻嗪类铁死亡抑制剂及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
DE3942227A1 (de) * | 1989-12-21 | 1991-06-27 | Bayer Ag | Triarylmethan-farbbildner |
GB9310635D0 (en) * | 1993-05-21 | 1993-07-07 | Glaxo Group Ltd | Chemical compounds |
WO1995004723A1 (fr) * | 1993-08-04 | 1995-02-16 | Yamanouchi Pharmaceutical Co., Ltd. | Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive |
-
1994
- 1994-09-28 AU AU77071/94A patent/AU679119B2/en not_active Ceased
- 1994-09-28 NZ NZ273681A patent/NZ273681A/en unknown
- 1994-09-28 EP EP94927788A patent/EP0721943A4/en not_active Withdrawn
- 1994-09-28 US US08/619,629 patent/US5807880A/en not_active Expired - Fee Related
- 1994-09-28 HU HU9600813A patent/HUT75871A/hu unknown
- 1994-09-28 KR KR1019960701595A patent/KR960704852A/ko not_active Withdrawn
- 1994-09-28 CN CN94193503A patent/CN1131944A/zh active Pending
- 1994-09-28 WO PCT/JP1994/001593 patent/WO1995009157A1/ja not_active Application Discontinuation
- 1994-09-28 CA CA002170874A patent/CA2170874A1/en not_active Abandoned
- 1994-09-28 PL PL94313769A patent/PL313769A1/xx unknown
-
1996
- 1996-03-29 FI FI961418A patent/FI961418L/sv unknown
- 1996-03-29 NO NO961274A patent/NO961274L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR960704852A (ko) | 1996-10-09 |
HUT75871A (en) | 1997-05-28 |
AU679119B2 (en) | 1997-06-19 |
CN1131944A (zh) | 1996-09-25 |
CA2170874A1 (en) | 1995-04-06 |
FI961418A0 (sv) | 1996-03-29 |
HU9600813D0 (en) | 1996-05-28 |
NO961274D0 (no) | 1996-03-29 |
NZ273681A (en) | 1996-09-25 |
WO1995009157A1 (en) | 1995-04-06 |
EP0721943A4 (en) | 1996-09-04 |
PL313769A1 (en) | 1996-07-22 |
US5807880A (en) | 1998-09-15 |
EP0721943A1 (en) | 1996-07-17 |
NO961274L (no) | 1996-03-29 |
AU7707194A (en) | 1995-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961418L (sv) | Azolderivat och dess farmaceutisk blandning | |
BR1100824A (pt) | Composto e composição farmacêutica | |
FI961599A (sv) | 1N-alkyl-N-arylpyrimidinaminer och derivat därav | |
BR1100329A (pt) | Composto e formulação farmacêutica | |
FI944832A0 (sv) | Farmaceutisk sammansättning | |
FI941747L (sv) | Kompositioner och deras användnigar | |
FI941137L (sv) | 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa | |
FI943345L (sv) | Organalumoxanprodukter och deras användning | |
FI945476L (sv) | Sammansättningar med fördröjd frigörning och förfarande för framställning av farmaceutiska sammansättningar | |
BR9500784A (pt) | Composto e formulação farmacêutica | |
BR9504060A (pt) | Composto e formulação farmacêutica | |
FI953479A0 (sv) | 1-arylpyrimidinderivat och farmaceutisk användning av dessa | |
FI940640L (sv) | Organoaluminoxyprodukter samt användning | |
FI945434L (sv) | 4-merkaptoacetylamino-/2/benzazepinone(3) derivat och användning av dessa som enkefalinasinhibitorer | |
PT703954E (pt) | Composicoes de derivados de polifenois e sua preparacao | |
BR9200058A (pt) | Composto e composicao farmaceutica | |
FI960867A (sv) | Bensazepinderivat, dess farmaceutisk blandning och mellanprodukt | |
ITMI932540A0 (it) | Composizione farmaceutica | |
BR9509688A (pt) | Composto e composição farmacêutica | |
FI960487L (sv) | Bensopyraner och dessa innehållande farmaceutiska kompositioner | |
FI943705L (sv) | Farmaceutiska kompositioner | |
FI971462L (sv) | Bensioxazolderivat och bekämpningsmedelssammansättningar innehållande desamma | |
LV10579A (lv) | Farmaceitiska kompozicija | |
FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
FI956235L (sv) | 17-halogen-4-aza-androstenderivat och förfarande för framställning av dem |